Also, there was no statistically significant difference in the clinical data such as hepatomgaly and lymphadenopathy between the patients with SALL4 gene expression ≤ 1.0 RQ and patients > 1.0 RQ (with p value=0.09 and 0.25 respectively). This evidence concerns the gene SALL4 and Lymphadenopathy.